Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Actinium-225

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Bayer starts Ph I using Actinium-225 on GPC3 in liver Carcinoma
    Bayer starts Ph I using Actinium-225 on GPC3 in liver Carcinoma

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429877323/en/Bayer-Initiates-Phase-I-Study-Targeting-GPC3-With-Actinium-225-Radiopharmaceutical-in-Patients-With-Advanced-Hepatocellular-Carcinoma

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement
    ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067172/0/en/ITM-and-Alpha-9-Oncology-Enter-Into-Supply-Agreement-for-Therapeutic-Medical-Radioisotope-Actinium-225.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Actinium Pharma Announces ATNM-400 Prostate Cancer Radiotherapy
    Actinium Pharma Announces ATNM-400 Prostate Cancer Radiotherapy

    27 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-announces-atnm-400-a-novel-non-psma-targeting-first-in-class-prostate-cancer-radiotherapy-leveraging-actinium-225-302412945.html

    PR NEWSWIRE
    27 Mar 2025
    Share Share
    Actinium Pharmaceuticals Business Update After Mar-A-Lago Present
    Actinium Pharmaceuticals Business Update After Mar-A-Lago Present

    27 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/actinium-pharmaceuticals-provides-business-update-after-presentation-at-trump-mar-a-lago-club-announcing-novel-non-psma-prostate-cancer-radiotherapy-atnm-400-and-outlining-revitalized-clinical-pipeline-with-2025-corporate-objectiv-302413074.html

    PR NEWSWIRE
    27 Mar 2025
    Share Share
    NorthStar Medical & Ariceum Announce Actinium-225 Supply Agreement
    NorthStar Medical & Ariceum Announce Actinium-225 Supply Agreement

    11 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241211286901/en

    BUSINESSWIRE
    11 Dec 2024
    Share Share
    Actineer Begins Production Of Actinium-225 Joint Venture
    Actineer Begins Production Of Actinium-225 Joint Venture

    18 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241018503210/en

    BUSINESSWIRE
    18 Oct 2024
    Share Share